Brown, Lisle/Cummings’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.9K Sell
905
-854
-49% -$74.9K 0.02% 330
2026
Q1
$159K Buy
1,759
+59
+3% +$5.41K 0.04% 240
2025
Q4
$153K Hold
1,700
0.04% 237
2025
Q3
$167K Hold
1,700
0.04% 225
2025
Q2
$155K Hold
1,700
0.04% 236
2025
Q1
$192K Hold
1,700
0.06% 204
2024
Q4
$180K Sell
1,700
-300
-15% -$32.2K 0.05% 211
2024
Q3
$216K Sell
2,000
-288
-13% -$31.4K 0.07% 198
2024
Q2
$248K Sell
2,288
-162
-7% -$19.1K 0.08% 184
2024
Q1
$323K Hold
2,450
0.11% 163
2023
Q4
$298K Sell
2,450
-175
-7% -$19.5K 0.11% 166
2023
Q3
$295K Hold
2,625
0.13% 147
2023
Q2
$382K Buy
2,625
+1,700
+184% +$231K 0.17% 129
2023
Q1
$120K Hold
925
0.06% 207
2022
Q4
$118K Sell
925
-250
-21% -$29K 0.06% 199
2022
Q3
$123K Hold
1,175
0.07% 192
2022
Q2
$123K Hold
1,175
0.07% 193
2022
Q1
$150K Buy
1,175
+16
+1% +$1.93K 0.07% 189
2021
Q4
$143K Buy
+1,159
New +$152K 0.07% 188

Other funds holding ZBH

Brown, Lisle/Cummings's ZBH Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Zimmer Biomet (ZBH) stake by 49% in Q2 2026, selling an estimated $74.9K and leaving 905 shares worth $77.9K. The position accounts for 0.02% of the portfolio, ranked #330.

Brown, Lisle/Cummings first reported a position in ZBH in Q4 2021 and has held it in 19 quarters since. The position peaked at $382K in Q2 2023. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Brown, Lisle/Cummings held 905 shares of Zimmer Biomet worth $77.9K as of Q2 2026.
  • Brown, Lisle/Cummings sold 854 Zimmer Biomet shares in Q2 2026, an estimated $74.9K.
  • Zimmer Biomet made up 0.02% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #330 holding.
  • Brown, Lisle/Cummings first reported a position in Zimmer Biomet in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Zimmer Biomet position peaked at $382K in Q2 2023.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.